Fundacio Puigvert — Barcelona

Public research footprint of Fundacio Puigvert, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Autosomal Dominant Polycystic Kidney · Alport Syndrome · Non-muscle Invasive Bladder Cancer With Carcinoma in Situ · Endoscopic Anatomical Enucleation of the Prostate (EEAP)

Recently updated registry entries

NCT07483827 — A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in… (Recruiting)
NCT07161037 — Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene… (Active Not Recruiting)
NCT07280585 — STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Fundacio Puigvert?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.